Schroder Investment Management Group Sells 3,004 Shares of Revvity, Inc. (NYSE:RVTY)

Schroder Investment Management Group decreased its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 39.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 4,571 shares of the company's stock after selling 3,004 shares during the quarter. Schroder Investment Management Group's holdings in Revvity were worth $509,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Victory Capital Management Inc. increased its holdings in shares of Revvity by 17.4% during the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company's stock worth $7,841,000 after buying an additional 10,390 shares in the last quarter. JPMorgan Chase & Co. grew its position in Revvity by 13.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company's stock worth $43,961,000 after acquiring an additional 41,497 shares during the last quarter. Contravisory Investment Management Inc. increased its holdings in Revvity by 1,715.9% during the 4th quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company's stock valued at $7,722,000 after purchasing an additional 65,376 shares in the last quarter. FMR LLC raised its position in Revvity by 40.8% in the 3rd quarter. FMR LLC now owns 155,556 shares of the company's stock valued at $19,872,000 after purchasing an additional 45,040 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its stake in Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company's stock worth $881,000 after purchasing an additional 3,672 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Remove Ads

Analyst Ratings Changes

RVTY has been the subject of a number of research analyst reports. Sanford C. Bernstein cut Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Barclays dropped their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research note on Thursday. Raymond James reissued an "outperform" rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Bank of America raised shares of Revvity from a "neutral" rating to a "buy" rating and set a $138.00 price target for the company in a report on Friday, December 13th. Finally, KeyCorp upped their price objective on Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $133.75.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.68% of the stock is owned by corporate insiders.

Revvity Trading Up 1.8 %

NYSE RVTY traded up $1.67 on Friday, reaching $94.69. The company had a trading volume of 2,420,772 shares, compared to its average volume of 886,179. The company has a quick ratio of 3.03, a current ratio of 3.60 and a debt-to-equity ratio of 0.41. Revvity, Inc. has a 52 week low of $89.61 and a 52 week high of $129.50. The stock has a market cap of $11.38 billion, a price-to-earnings ratio of 42.84, a PEG ratio of 3.82 and a beta of 1.07. The stock's 50 day moving average is $109.12 and its 200-day moving average is $115.17.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the prior year, the business posted $1.25 EPS. Equities analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.30%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity's dividend payout ratio (DPR) is 12.67%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.